Get. Software. Done.

In this episode of the SciMed Biotech Podcast, we dive into the world of orthodontic innovation with Dr. Ahmet Keles and Eren Keles of Aegis Star Dental Technologies. Dr. Ahmet, a seasoned inventor and Chief Medical Officer, alongside CEO Eren, explore the genesis and impact of their groundbreaking devices like the "Keles Keyless Expander." They share insights into blending clinical expertise with cutting-edge design to revolutionize dental care. Listen in as they discuss the challenges and triumphs of bringing novel orthodontic solutions from concept to market, aiming to enhance patient comfort and clinical outcomes in dental practices globally.

This episode features an exciting conversation with Matthew Gdovin, the Founder and Chief Science Officer of Vitanova Biomedical. Delve into the technology behind Vitanova’s cancer treatments as Matthew explains their proprietary light-activated intracellular acidosis (LAIA) therapy, which targets cancer cells with precision. We'll explore how this innovative approach uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death, a technique poised to revolutionize cancer therapy. Matthew also shares insights from his rich career in cancer research, the challenges of bringing such technology from the lab to the clinic, and the future of cancer treatment innovations.

Noah Zimmerman, Chief Science Officer at Verb Biotics, takes us on a journey through the frontiers of microbiome research. Noah brings over two decades of expertise in biotechnology, where he has pioneered methods for harnessing the microbiome to enhance health through functional metabolites. In this episode, Noah discusses how integrating vast datasets with machine learning transforms our approach to disease treatment and wellness enhancement. He shares insights into the challenges of translating complex microbiome data into practical health solutions, and Verb Biotics' innovative strategies to develop biotics that improve mental and digestive health by influencing the gut-brain axis. Whether you're a professional in the health sector or keen on the latest in biotech innovation, this episode is packed with valuable knowledge on the cutting-edge of science and well-being.

In this episode of the SciMed Biotech Podcast, we sit down with Hugh McTavish, a man whose personal and professional life exemplifies the power of resilience. As the founder and CEO of SquareX Pharmaceutical Corporation and IGF Oncology, Hugh shares his unique journey from facing personal health challenges to pioneering new treatments in both cancer therapy and viral outbreaks.

Beyond his scientific achievements, Hugh is also the Executive Director of COVID-Sanity.org, a platform he founded in response to the social and psychological impacts of the COVID-19 lockdowns. His stance against the measures reflects his broader commitment to addressing overlooked issues in public health and policy.

Join us as Hugh discusses the intersections of his work as a biochemist, immunologist, and patent attorney, and how these diverse fields inform his approach to drug development. He also shares insights into the challenges of navigating the pharmaceutical industry, from securing patents to fostering strategic partnerships.

Dive into the world of sustainable biotechnology in this episode of the SciMed Biotech Podcast, where we explore the innovative work of KnipBio. Under the leadership of CEO Larry Feinberg, KnipBio is at the forefront of developing a novel platform that produces high-quality, sustainable animal feed designed to address the pressing challenges of food security, climate change, and animal welfare.

Larry Feinberg brings nearly two decades of experience in the biotech industry to his role, where his expertise in microbiology and early-stage technology ventures is transforming the way we think about animal nutrition. By focusing on a triple bottom line—people, planet, profit—Larry and his team are not just creating feed; they're pioneering solutions that promote environmental harmony while enhancing the health and efficiency of livestock industries globally.

In this episode, Larry shares insights into the journey of KnipBio, from its inception to becoming a leader in the field of sustainable biotech. He discusses the strategic partnerships and funding successes that have propelled the company forward, as well as the scientific breakthroughs that make their feed alternatives both effective and environmentally friendly.

Join us on the SciMed Biotech Podcast where we sit down with Karthik Musunuri, CEO of Avstera Therapeutics. Karthik brings a wealth of experience from big pharma and his own entrepreneurial ventures to his current role, where he's focused on developing new immunomodulators that promise to redefine cancer care.

In this conversation, Karthik shares how his earlier roles, from leading sales teams at Merck to steering vaccine strategy at GSK, laid the groundwork for his latest venture. He details the steps from operating high-complexity labs to steering Avstera through the complex waters of FDA approvals. Now, he’s channeling his energy into Avstera Therapeutics, where groundbreaking work on manipulating tumor micro-environments offers new hope in oncology.

You’ll get an inside look at how Avstera’s partnerships with top research institutions like Georgetown University and the University of Pennsylvania are critical to their mission. Karthik also opens up about the challenges they face in the fast-evolving field of cancer immunotherapy and the milestones they’ve reached that keep their team driven.

In this episode of the SciMed Biotech Podcast, join Dr. Shane Hegarty, the visionary Chief Scientific Officer and Co-Founder of Axonis Therapeutics, as he shares his journey into the world of neurotherapeutics. With a career that bridges deep scientific research and innovative biotech entrepreneurship, Dr. Hegarty reveals how his personal experiences and scientific expertise have culminated in the development of Axonis's pioneering treatments for neurological disorders.

Discover how Axonis, leveraging insights from cutting-edge genome-wide AAV-CRISPR screens and the leadership in KCC2 biology, is poised to transform the treatment landscape for conditions like epilepsy, pain, and other CNS pathologies. Dr. Hegarty discusses the challenges and successes of transitioning from academia to the biotech industry, his strategic approach to overcoming funding obstacles, and the exciting potential of KCC2 potentiators that Axonis is bringing to clinical trials.

Tune in to learn how Dr. Hegarty's passion for science and commitment to patient care are driving innovations that promise to significantly improve the lives of those suffering from debilitating neurological conditions. This episode is not just a tale of scientific achievement but a compelling look at how visionary leadership can turn promising research into life-changing therapeutic applications.

In this episode of the SciMed Biotech Podcast we dive into the world of genomics with Leeland Ekstrom, CEO and co-founder of Nashville Biosciences. This unique biotech firm is leveraging the massive genomic and bioinformatics resources of Vanderbilt University Medical Center to accelerate the discovery and development of new therapeutics and diagnostics.

Leeland brings a rich background from his time at McKinsey, where he led initiatives in personalized medicine and R&D productivity, to his pioneering work at Nashville Biosciences. He shares how his team uses advanced technology and novel algorithms to extract crucial genetic insights from BioVU®, Vanderbilt’s extensive biobank, transforming the DNA of life science research and speeding up the time-to-market for vital healthcare solutions.

Tune in to learn about the challenges and triumphs of integrating large-scale genomic data into practical applications that not only promise to enhance R&D efficiency but also pave the way for more personalized medicine approaches in healthcare.

Join us on this episode of the SciMed Biotech Podcast as we dive into the world of nutripharma with Erin Owen and Kim Biedermann from Mend Labs. Erin, Vice President of Clinical Research & Digital Health, and Kim, Chief Science Officer, discuss how their work at Mend Labs is not just changing, but revitalizing the way we approach recovery and healing. They'll share insights into the development of their innovative products that combine nature's power with scientific backing to improve surgical outcomes and enhance patient recovery.

Tune in to discover how Mend Labs is making significant strides in healthcare by focusing on personalized nutrition and patient care. Whether you're a healthcare professional or simply interested in the future of medical science, this episode is packed with enlightening discussions that showcase the transformative impact of nutripharma.

In this episode of the SciMed Biotech Podcast, we are joined by Dr. Nick Love, Co-Founder and CEO of Love Lifesciences, who takes us through the journey of developing UniPen, a revolutionary safety injection device aimed at transforming patient care. Dr. Love shares insights into the inspiration behind founding Love Lifesciences during his medical training and the challenges and triumphs of bringing a medical device from concept to market. He dives into how his background in medicinal chemistry and pediatric neurodevelopment has uniquely positioned him to address critical needs in medical injections, enhancing patient safety and improving therapeutic outcomes. Listen in to learn about the technology behind UniPen and how Love Lifesciences is setting new standards in the medical device industry by prioritizing patient-centered design and safety.

In this episode of the SciMed Biotech Podcast, we explore the the exciting science of neurotechnology with Susan and Tessa Santarpia from VisualizeIn360. Susan, a neuropsychologist, and Tessa, a flow and meditation coach, combine their expertise to discuss how their innovative company is pioneering the use of immersive neurotechnology to enhance mental and physical well-being. They delve into how VisualizeIn360 aims to bridge the gap between technology and holistic health practices, making advanced wellness interventions more accessible and effective. Listen in as they share insights into their journey of creating a platform that not only supplements existing therapeutic methods but also empowers individuals to unlock their full potential and achieve unprecedented states of health and consciousness.

In this episode of the SciMed Biotech Podcast, we sit down with Dr. Benjamin Fryer, co-founder and CEO of Pluristyx, to explore his trailblazing work in stem cell research. Dr. Fryer, with a rich background that spans academia, start-ups, and big pharma, has been at the forefront of developing therapies that could one day revolutionize how we treat diseases. At Pluristyx, he's helping to push the boundaries of medicine by making it easier for other companies to develop and commercialize new treatments. Join us as Dr. Fryer shares insights from his journey in science and leadership, and explains how his team's work is opening up new possibilities for health and healing. This conversation is perfect for anyone curious about the future of healthcare and the innovative technologies that will drive it.